Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion
- Conditions
- Pain
- Interventions
- Drug: Lidocaine-Prilocaine CreamDrug: Placebo CreamDrug: 1% Lidocaine Paracervical Block
- Registration Number
- NCT03508804
- Lead Sponsor
- Stanford University
- Brief Summary
The investigators theorize that the application of a lidocaine-prilocaine cream 5-10 minutes prior to the administration of a paracervical block could decrease pain associated with its administration and pain with abortion overall.
- Detailed Description
This is a superiority, double-blind randomized controlled trail of women ages 18 and older presenting for first-trimester surgical abortion. The lidocaine-prilocaine cream will be used in the experimental group in conjunction with a paracervical block, whereas plain lubricating gel will be used in conjunction with a paracervical block for the placebo, control group.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- surgical abortion patient at 5 0/7 to 11 6/7 weeks gestational age;
- English or Spanish speaking;
- ability to give informed consent
- pre-operative use of misoprostol;
- allergy to study medications (lidocaine, prilocaine, versed, fentanyl);
- known uterine anomaly;
- prior cervical surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo cream (pain lucubrating gel) 1% Lidocaine Paracervical Block 5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the placebo cream vaginally using a syringe Lidocaine-prilocaine cream Lidocaine-Prilocaine Cream 5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the lidocaine-prilocaine cream vaginally using a syringe Lidocaine-prilocaine cream 1% Lidocaine Paracervical Block 5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the lidocaine-prilocaine cream vaginally using a syringe Placebo cream (pain lucubrating gel) Placebo Cream 5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the placebo cream vaginally using a syringe
- Primary Outcome Measures
Name Time Method Pain perceived as measured by a Visual Analog Scale (0-100mm) at the time of cervical dilation Intraoperative; Immediately following cervical dilation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford Health Care
🇺🇸Stanford, California, United States